Lilly (Eli) (LLY) price target — analyst by analyst

Lilly (Eli) · Health Care · ref. ETF XLV · price $1176.1
Logo Lilly (Eli)See the full Lilly (Eli) (LLY) profile
By Rédaction JPI Invest · updated
In short — 15 price targets published on Lilly (Eli) over 90 days: 15 bullish, 0 bearish (100% positive), median target $1,370. The highest-ranked firm to weigh in is Cantor Fitzgerald (rank 11, 57.8% hit rate). For each call below we show the firm's real track record — not just its opinion.

The last 15 analyst calls on LLY

Newest first. The "verdict" is our read on the firm, based on its past calls replayed against actual prices.

Bullish
Truist Securities · Buy · target $1,376 (+16% vs price that day)
Our verdict — Truist Securities ranks #51 of 64 in our leaderboard: 85.7% hit rate on Lilly (Eli) (14 scored calls on this stock), 14.6% average gain per call, +3 pts vs its sector.
Bullish
Wells Fargo · Overweight · target $1,330 (+12% vs price that day)
Our verdict — Wells Fargo ranks #47 of 64 in our leaderboard: 90.9% hit rate on Lilly (Eli) (11 scored calls on this stock), 14.5% average gain per call, +3 pts vs its sector.
Bullish
Cantor Fitzgerald · Overweight · target $1,410 (+18% vs price that day)
Our verdict — Cantor Fitzgerald ranks #11 of 64 in our leaderboard: 66% hit rate on Lilly (Eli) (47 scored calls on this stock), 37.1% average gain per call, +12 pts vs its sector.
Bullish
Citigroup · Buy · target $1,600 (+37% vs price that day)
Our verdict — Citigroup ranks #24 of 64 in our leaderboard: 87.5% hit rate on Lilly (Eli) (8 scored calls on this stock), 20.1% average gain per call, +5 pts vs its sector.
Bullish
Bernstein · Outperform · target $1,385 (+20% vs price that day)
Our verdict — Bernstein ranks #50 of 64 in our leaderboard: 63.7% hit rate across all stocks, 13.5% average gain per call, +3 pts vs its sector.
Bullish
UBS · Buy · target $1,425 (+24% vs price that day)
Our verdict — UBS ranks #27 of 64 in our leaderboard: 100% hit rate on Lilly (Eli) (6 scored calls on this stock), 17% average gain per call, +5 pts vs its sector.
Bullish
Guggenheim · Buy · target $1,273 (+8% vs price that day)
Our verdict — Guggenheim ranks #40 of 64 in our leaderboard: 75% hit rate on Lilly (Eli) (8 scored calls on this stock), 14.3% average gain per call, +4 pts vs its sector.
Bullish
B of A Securities · Buy · target $1,334 (+13% vs price that day)
Our verdict — B of A Securities ranks #31 of 64 in our leaderboard: 62.5% hit rate on Lilly (Eli) (8 scored calls on this stock), 17.5% average gain per call, +5 pts vs its sector.
Bullish
Truist Securities · Buy · target $1,370 (+13% vs price that day)
Our verdict — Truist Securities ranks #51 of 64 in our leaderboard: 85.7% hit rate on Lilly (Eli) (14 scored calls on this stock), 14.6% average gain per call, +3 pts vs its sector.
Bullish
Morgan Stanley · Overweight · target $1,347 (+11% vs price that day)
Our verdict — Morgan Stanley ranks #49 of 64 in our leaderboard: 94.7% hit rate on Lilly (Eli) (38 scored calls on this stock), 12.2% average gain per call, +3 pts vs its sector.
Bullish
RBC Capital · Outperform · target $1,500 (+23% vs price that day)
Our verdict — RBC Capital ranks #62 of 64 in our leaderboard: 61.2% hit rate across all stocks, 9% average gain per call, -2 pts vs its sector.
Bullish
JP Morgan · Overweight · target $1,400 (+13% vs price that day)
Our verdict — JP Morgan ranks #37 of 64 in our leaderboard: 88.2% hit rate on Lilly (Eli) (17 scored calls on this stock), 15.8% average gain per call, +4 pts vs its sector.
Bullish
Cantor Fitzgerald · Overweight · target $1,350 (+12% vs price that day)
Our verdict — Cantor Fitzgerald ranks #11 of 64 in our leaderboard: 66% hit rate on Lilly (Eli) (47 scored calls on this stock), 37.1% average gain per call, +12 pts vs its sector.
Bullish
Leerink Partners · Outperform · target $1,232 (+2% vs price that day)
Our verdict — Leerink Partners ranks #63 of 64 in our leaderboard: 60.5% hit rate across all stocks, -0.7% average gain per call, -5 pts vs its sector.
Bullish
Jefferies · Buy · target $1,350 (+19% vs price that day)
Our verdict — Jefferies ranks #30 of 64 in our leaderboard: 58.3% hit rate on Lilly (Eli) (12 scored calls on this stock), 16.5% average gain per call, +5 pts vs its sector.

⚠️ Price targets as published by the firms, timestamped at their publication date. The upside shown is vs the price on the day of the call, not today's price. Informational data, not investment advice.

Frequently asked questions

What are analysts saying about LLY right now?

Over the last 90 days, 15 price targets were published on Lilly (Eli): 15 bullish and 0 bearish (100% positive). The median target is $1,370. The latest call is from August 7, 2026.

Should you trust these price targets?

Not blindly — that's the point of this page: next to each call we show the firm's real track record — its rank among 64 tracked firms, its hit rate and its average gain per call. An ambitious target from a firm that is wrong 6 times out of 10 is not worth the same as one from a consistent firm.

Which firm covering LLY is the most reliable?

Among the firms that published on Lilly (Eli) in the last 90 days, our highest-ranked is Cantor Fitzgerald (rank 11 of 64, 57.8% hit rate, 37.1% average gain per call).

Where does this data come from?

From analyst price targets, timestamped at publication then replayed against the actual price. Firm rankings come from our analyst leaderboard. Updated daily.

💬 A question about Lilly (Eli)? The JPI assistant answers using our backtest data.
Keep exploring Lilly (Eli)
JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)